Private Companies Are Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Biggest Owners and Were Hit After Market Cap Dropped CN¥1.1b
Private Companies Are Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Biggest Owners and Were Hit After Market Cap Dropped CN¥1.1b
Key Insights
主要见解
- Micro-Tech (Nanjing)Ltd's significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public
- The top 4 shareholders own 52% of the company
- 21% of Micro-Tech (Nanjing)Ltd is held by Institutions
- 南微医学(南京)有限公司的显著股权由私营公司持有,这表明关键决策受到了较大公众股东的影响。
- 前4大股东拥有该公司的52%。
- 21%的南微医学(南京)有限公司的股份由机构持有。
Every investor in Micro-Tech (Nanjing) Co.,Ltd (SHSE:688029) should be aware of the most powerful shareholder groups. We can see that private companies own the lion's share in the company with 25% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
每一位投资者在南微医学(南京)有限公司(SHSE:688029)应当了解最强大的股东群体。我们可以看到,私营公司在该公司拥有25%的股份,也就是说,该团体在投资该公司中获得的收益最大(或损失最大)。
As a result, private companies as a group endured the highest losses last week after market cap fell by CN¥1.1b.
因此,上周私营企业整体承受了最高的损失,因为市值减少了11亿人民币。
Let's delve deeper into each type of owner of Micro-Tech (Nanjing)Ltd, beginning with the chart below.
让我们从下面的图表深入了解南微医学(南京)有限公司的每种类型的所有者。
What Does The Institutional Ownership Tell Us About Micro-Tech (Nanjing)Ltd?
机构所有权告诉我们关于南微医学(南京)有限公司什么?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
许多机构衡量其业绩的标准是一个近似于当地市场的指数。因此,他们通常更加关注包括在主要指数中的公司。
Micro-Tech (Nanjing)Ltd already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Micro-Tech (Nanjing)Ltd's historic earnings and revenue below, but keep in mind there's always more to the story.
南微医学(南京)有限公司已经在股份登记上有机构投资者。实际上,他们在公司的股份相当可观。这表明在专业投资者中具有一定的可信度。但我们不能仅仅依赖这一事实,因为机构有时也会做出不好的投资,就像每个人一样。当多个机构持有一只股票时,总是存在‘拥挤交易’的风险。当这样的交易出现问题时,多个方可能会竞相快速出售股票。在没有增长历史的公司中,这种风险会更高。您可以在下面看到南微医学(南京)有限公司的历史收益和营业收入,但请记住,故事远不止于此。
We note that hedge funds don't have a meaningful investment in Micro-Tech (Nanjing)Ltd. China Science & Merchants Investment Management Group Co., Ltd. is currently the company's largest shareholder with 22% of shares outstanding. Nanjing New Weichuang Enterprise Management Consulting Co., Ltd. is the second largest shareholder owning 20% of common stock, and National Council for Social Security Fund holds about 5.5% of the company stock. Additionally, the company's CEO Derong Leng directly holds 1.3% of the total shares outstanding.
我们注意到对南微医学(南京)有限公司的对冲基金投资并不显著。中国科学与商贸投资管理集团有限公司目前是该公司的最大股东,持有22%的流通股份。南京新维创企业管理咨询有限公司是第二大股东,持有20%的普通股,国家社会保障基金理事会持有大约5.5%的公司股票。此外,公司的CEO雷荣直接持有总流通股份的1.3%。
To make our study more interesting, we found that the top 4 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.
为了使我们的研究更有趣,我们发现前四名股东控制了公司一半以上的股份,这意味着该集团对公司的决策具有相当大的影响力。
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.
尽管研究公司的机构持股可以增加您的研究价值,但研究分析师的建议也是一个好习惯,以更深入地了解股票的预期表现。有相当数量的分析师关注该股,因此了解他们对未来的总体观点可能很有用。
Insider Ownership Of Micro-Tech (Nanjing)Ltd
南微医学(南京)有限公司的内部持股
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
虽然内部人员的精确定义可能具有主观性,但几乎所有人都认为董事会成员是内部人员。管理层最终向董事会负责。然而,如果经理是创始人或CEO,那么他们成为执行董事会成员并不罕见。
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
当内部人持股情况表明领导层思考和公司真正所有者一样时,内部所有权是积极的。然而,高达内部人士所有权也可能为公司内的小团体带来巨大的权力。在某些情况下,这可能是负面的。
Our most recent data indicates that insiders own some shares in Micro-Tech (Nanjing) Co.,Ltd. This is a big company, so it is good to see this level of alignment. Insiders own CN¥400m worth of shares (at current prices). It is good to see this level of investment by insiders. You can check here to see if those insiders have been buying recently.
我们最近的数据表明,内部人士拥有南微医学(南京)有限公司的部分股份。 这是一家大公司,因此看到这样的对齐水平是很好的。内部人士拥有价值40000万人民币的股份(按当前价格计算)。看到内部人士的这种投资水平是很好的。您可以在这里查看这些内部人士是否最近有买入。
General Public Ownership
一般大众所有权
With a 24% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Micro-Tech (Nanjing)Ltd. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
公众持有24%的股份,主要是由个人投资者组成,对南微医学(南京)有限公司有一定的影响力。尽管这个股份规模相当可观,但如果决策与其他大股东不同,这可能不足以改变公司政策。
Private Equity Ownership
股权投资公司持有8.8%的股份,有能力参与塑造以价值创造为重点的公司策略。一些投资者可能会因此而受到鼓舞,因为股权投资公司有时可以鼓励市场看到公司的价值,从而采取有益的策略。另外,那些持有者可能在将其上市后退出投资。
With an ownership of 22%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.
私人股权公司持有22%的所有权,可以在价值创造方面发挥塑造企业战略的作用。 有些投资者可能会因此感到鼓舞,因为私募股权有时能够鼓励帮助市场看到公司的价值的策略。 或者,这些持有人在把它上市后就退出了投资。
Private Company Ownership
私有公司的所有权
We can see that Private Companies own 25%, of the shares on issue. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.
我们可以看到,私有公司拥有公司已发行的25%股份。仅从这个事实很难得出结论,因此有必要查看谁拥有这些私有公司。有时候内部人员或其他相关方会通过单独的私人公司持有以公开公司的股份的权益。
Next Steps:
下一步:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Micro-Tech (Nanjing)Ltd , and understanding them should be part of your investment process.
我发现研究谁真正拥有一家公司非常有趣。但是要真正获得洞察,我们还需要考虑其他信息。 举个例子,投资风险这个无处不在的幽灵。 我们已经识别出南微医学(南京)有限公司的一个警告信号,理解这些信号应该是您投资过程的一部分。
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
如果您像我一样,可能希望考虑这家公司是否会增长或缩小。幸运的是,您可以查看此免费报告,显示分析师对其未来的预测。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。